Henning Nilius
Overview
Explore the profile of Henning Nilius including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Assar M, Nilius H, Kearn N, Hopman W, Nagler M, Othman M
Int J Lab Hematol
. 2025 Feb;
PMID: 39980259
Introduction: Thrombophilia, a blood coagulation disorder, poses risks of venous thromboembolism (VTE). Coagulation assays may not be sufficient to assess VTE risk and global assays such as Rotational Thromboelastometry (ROTEM)...
2.
Strajhar P, Berzigotti A, Nilius H, Nagler M, Dufour J
PLoS One
. 2025 Jan;
20(1):e0317629.
PMID: 39854322
Background & Aims: Chronic liver diseases pose a serious public health issue. Identifying patients at risk for advanced liver fibrosis is crucial for early intervention. The Fibrosis-4 score (FIB-4), a...
3.
Rufer A, Nilius H, Hermine O, Niedoszytko M, Oude Elberink J, Bonadonna P, et al.
Leukemia
. 2025 Jan;
39(3):675-683.
PMID: 39815050
Expression of CD2, CD25 and/or CD30 in extracutaneous mast cells (MC) is a minor diagnostic criterion for systemic mastocytosis (SM) in the classification of the World Health Organization and International...
4.
Boschetti L, Nilius H, Ten Cate H, Wuillemin W, Faes L, Bossuyt P, et al.
Front Cardiovasc Med
. 2024 Dec;
11:1420000.
PMID: 39677032
Background: Early detection and diagnosis of venous thromboembolism are vital for effective treatment. To what extent methodological shortcomings exist in studies of diagnostic tests and whether this affects published test...
5.
Jeker B, Thalmann L, Bacher U, Nilius H, Rhyner G, Sokler M, et al.
Bone Marrow Transplant
. 2024 Nov;
60(3):270-276.
PMID: 39548306
In fit patients with newly diagnosed myeloma, high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation (ASCT) is considered standard of care. For mobilization of CD34+ cells for ASCT, combined...
6.
Nilius H, Naas S, Studt J, Tsakiris D, Greinacher A, Mendez A, et al.
J Thromb Haemost
. 2024 Nov;
23(2):684-691.
PMID: 39536820
Background: Following the current guidelines, immunoassays for the diagnosis of heparin-induced thrombocytopenia (HIT) are interpreted dichotomously, with test results categorized as either positive or negative. However, the extent to which...
7.
Nilius H, Nagler M
Hamostaseologie
. 2024 Nov;
44(6):459-465.
PMID: 39500343
The use of machine-learning (ML) algorithms in medicine has sparked a heated discussion. It is considered one of the most disruptive general-purpose technologies in decades. It has already permeated many...
8.
Heini A, Kammermann K, Bacher U, Jeker B, Hayoz M, Aebi Y, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409984
Introduction: The growing body of evidence around sexual and gender dimorphism in medicine, particularly in oncology, has highlighted differences in treatment response, outcomes, and side effects between males and females....
9.
Seipel K, Veglio N, Nilius H, Jeker B, Bacher U, Pabst T
Curr Issues Mol Biol
. 2024 Aug;
46(8):8197-8208.
PMID: 39194701
Multiple myeloma (MM) first-line treatment algorithms include immuno-chemotherapy (ICT) induction, high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) consolidation, followed by lenalidomide maintenance. After these initial therapies, most patients...
10.
Nagler M, Nilius H, Michielin G, Masoodi M, Largiader C
Pol Arch Intern Med
. 2024 Jun;
134(7-8).
PMID: 38884596
Laboratory tests play a central role in medicine, as they help to make diagnoses, assess prognosis and risk of disease, and monitor therapies, thus contributing to 70% of all medical...